Adrienne Farid sold $270k of IPSC
Chief Operations Officer at Century Therapeutics, Inc.. 53,515 shares at an average of $5.04, traded Mar 6, 2024, filed Mar 8, 2024.
Score components
- +20RoleCOO
- +13Trade size$270k at market
- +10Share of holdings soldSold 37% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-006058, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 6, 2024 | MOption exercise Common Stock10b5-1 | +30,684 | $1.03 | $32k | 144,833 | Mar 8, 2024 |
| Mar 6, 2024 | SOpen-market sale Common Stock10b5-1 | -30,684 | $4.96 | $152k | 114,149 | Mar 8, 2024 |
| Mar 7, 2024 | MOption exercise Common Stock10b5-1 | +22,831 | $1.03 | $24k | 136,980 | Mar 8, 2024 |
| Mar 7, 2024 | SOpen-market sale Common Stock10b5-1 | -22,831 | $5.14 | $117k | 114,149 | Mar 8, 2024 |
| Mar 6, 2024 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -30,684 | $0.00 | $0 | 191,486 | Mar 8, 2024 |
| Mar 7, 2024 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -22,831 | $0.00 | $0 | 168,655 | Mar 8, 2024 |
Related signals
Other insiders at Century Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $3,200 1,658 shares | -0% | |
| 23Weak | Century Therapeutics, Inc. | Gregory Russotti See Remarks | $4,993 2,587 shares | -1% | |
| 23Weak | Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $521 254 shares | -0% | |
| 23Weak | Century Therapeutics, Inc. | Gregory Russotti See Remarks | $1,095 534 shares | -0% | |
| 15Weak | IPSCsell Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $544 275 shares | -0% | |
| 23Weak | Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $3,692 1,654 shares | -0% | |
| 23Weak | Century Therapeutics, Inc. | Gregory Russotti See Remarks | $5,767 2,584 shares | -1% | |
| 23Weak | Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $526 249 shares | -0% | |
| 23Weak | Century Therapeutics, Inc. | Gregory Russotti See Remarks | $1,106 524 shares | -0% | |
| 15Weak | IPSCsell Century Therapeutics, Inc. | Douglas Carr SVP Finance & Operations | $618 264 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.